Sutro Biopharma
STRO
#9474
Rank
S$73 M
Marketcap
$0.87
Share price
-10.06%
Change (1 day)
-86.37%
Change (1 year)

Sutro Biopharma (STRO) - Cash on Hand

Cash on Hand as of December 2024 : S$0.42 Billion

According to Sutro Biopharma's latest financial reports the company has S$0.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sutro Biopharma - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.43 B-13.17%
2023-12-31S$0.49 B10.67%
2022-12-31S$0.44 B67.51%
2021-12-31S$0.26 B-45.06%
2020-12-31S$0.48 B206.49%
2019-12-31S$0.15 B-43.12%
2018-12-31S$0.27 B848.56%
2017-12-31S$29.45 M-57.18%
2016-12-31S$68.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$22.13 M-94.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.58 B 36.30%๐Ÿ‡บ๐Ÿ‡ธ USA